HK Stock MarketDetailed Quotes

06996 ANTENGENE-B

Watchlist
  • 1.040
  • -0.020-1.89%
Trading May 10 10:09 CST
701.88MMarket Cap-1094P/E (TTM)

ANTENGENE-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ANTENGENE-B Earnings Date

Currency: CNY

Period

FY2023 Annual Report

Mar 22, 2024

Revenue(YoY)

67.31M

-57.97%
EPS(YoY)

-0.94

+1.71%
Analyst Rating

Strong Buy

May 9, 2024

ANTENGENE-B Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 77.875M--
--2024/H1-- / 60.006M--
Mar 22, 20242023/H2-4.711M / 174.677M--
Aug 25, 20232023/H172.016M / 72.016M--
Mar 28, 20232022/H2106.179M / 127.160M--
Aug 30, 20222022/H153.960M / 54.000M--
Mar 18, 20222021/H228.769M / 10.000M--
Aug 20, 20212021/H10.000 / 0.000--
Mar 25, 20212020/H20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 77.875M--
--2024/H1-- / 60.006M--
Mar 22, 20242023/H2-4.711M / 174.677M
Deqi Pharmaceutical (6996.HK) 2023 Annual Results Conference
03/22 17:00
Replay
Aug 25, 20232023/H172.016M / 72.016M--
Mar 28, 20232022/H2106.179M / 127.160M
Deqi Pharmaceutical (6996.HK) 2022 Annual Results Conference
03/28 17:00
Replay
Aug 30, 20222022/H153.960M / 54.000M--
Mar 18, 20222021/H228.769M / 10.000M--
Aug 20, 20212021/H10.000 / 0.000--
Mar 25, 20212020/H20.000 / 0.000--
--------

Unlock Free Earnings Estimates

ANTENGENE-B Earnings Reports

  • ANTENGENE-B: 2023 ANNUAL REPORT

    Apr 29 17:03

  • ANTENGENE-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 AND PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND CHANGE IN USE OF PROCEEDS

    Mar 22 17:59

  • ANTENGENE-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 AND PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND CHANGE IN USE OF PROCEEDS

    Mar 22 16:41

  • ANTENGENE-B: NOTICE OF DATE OF BOARD MEETING

    Mar 11 16:30

    • Read more

    Analysis

    Analyst Rating

    Updated: May 9, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    %Chg